Navigation Links
Intalere Teams with Ambry Genetics to Offer Healthcare Providers Advanced Genetic Testing for Cancer Risk Assessment
Date:4/9/2019

Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, today announced a new partnership with Ambry Genetics, a leading clinical genetic testing company. The collaboration will enable Intalere to offer its healthcare providers access to state-of-the-art clinical genetic testing and family history assessment, so they may better identify and manage patients with a high risk for cancer due to an inherited genetic mutation through the Ambry CARE (Comprehensive Assessment, Risk, and Education) Program.

“Numerous studies have shown that individuals at high risk for inherited cancer are not receiving necessary and timely clinical genetic testing,” said Tom Schoenherr, chief commercial officer of Ambry Genetics. “Ambry Genetics’ CARE program is a unique, end to end, customizable program that’s designed to help healthcare systems address this problem. Through CARE, we are able to assess populations of at-risk groups, provide risk values, genetic testing if needed, and then, through genetic counseling, educate patients on how their results may impact their current and future health.”

The benefits of Ambry Genetics' CARE program are aligned with the triple AIM of healthcare, in that they are designed to improve the patient experience, enhance the health of populations, and reduce the per capita cost of healthcare by identifying cancers early and reducing the long-term costs of patient care.

Specifically, the CARE Program will benefit providers and patients by:

  • Providing personalized cancer risk information
  • Making recommendations for increased screening based on national guidelines
  • Identifying family members who may also be at risk
  • Integrating seamlessly into existing workflows

Tom Schoenherr stressed that the CARE program is customizable. “We understand that health systems all have unique needs and requirements, so we provide a dedicated team of specialists who evaluate where and how to best implement these programs.”

Shon Wettstein, vice president of business development at Intalere, views the partnership with Ambry as an excellent fit. “We continually seek to partner with like-minded organizations that set the highest standards in their industry,” said Wettstein. “Ambry provides unmatched accuracy and specificity in their testing, offering patients and their families the most reliable and comprehensive information to proactively evaluate risk and identify any areas of concern.”

About Intalere
Intalere’s mission focuses on elevating the operational health of America’s healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers’ individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare’s nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit http://www.intalere.com to learn more.

About Ambry Genetics
Ambry Genetics is a leader in clinical diagnostic and software solutions, combining both to offer comprehensive and high-quality genetic testing. As part of the Konica Minolta family, Ambry Genetics is responsibly applying new technologies to the molecular diagnostics market to bring about precision medicine. With over 20 years of experience, Ambry Genetics has longstanding expertise in clinical genetic testing. For more information about Ambry Genetics,
visit http://www.ambrygen.com.

Read the full story at https://www.prweb.com/releases/intalere_teams_with_ambry_genetics_to_offer_healthcare_providers_advanced_genetic_testing_for_cancer_risk_assessment/prweb16227294.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. OHSU teams with Intel to decode the root causes of cancer and other complex diseases
2. NREL teams with Navy, private industry to make jet fuel from switchgrass
3. Home teams hold the advantage
4. Western University primatologist teams with international group to save lemurs
5. NXT-ID, Inc. Teams Up with StackCommerce to Sell Wocket Smart Wallet for Holiday Season
6. EyeLock Teams With Diebold to Bring Iris Identity Authentication to Banking Customers
7. VoiceIt Teams Up With VoicePass
8. Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting
9. Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer
10. Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management
11. Genetics Society of Americas GENETICS journal highlights for May 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2019)... ... April 02, 2019 , ... Researchers from Ambry Genetics ... RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant ... poster, is one of 13 presentations at the 2019 American College of Medical ...
(Date:4/1/2019)... ... April 01, 2019 , ... ... Characterizing Skin Related Conditions” by the US Patent and Trademark Office on January ... an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:3/29/2019)... ... ... In the development of biosimilars, the broad definition of the similarity concept in ... several manufacturers have been successful and numerous follow-on biologics are approved in the US ... analytical similarity is achieved in biosimilars based on recently approved products in the US. ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... Utah and BOSTON (PRWEB) , ... April 08, ... ... delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch of ... integration to an unprecedented range of business and contact-orientated applications while using CT ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:4/4/2019)... (PRWEB) , ... April 03, 2019 , ... ... together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference ... offers insights into the industry’s challenges and opportunities with high-level panels and discussions ...
(Date:3/27/2019)... ... ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma has ... Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo to ...
Breaking Biology Technology: